These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka. Rao RU, Samarasekera SD, Nagodavithana KC, Goss CW, Punchihewa MW, Dassanayaka TDM, Ranasinghe USB, Mendis D, Weil GJ. Am J Trop Med Hyg; 2018 Sep; 99(3):735-742. PubMed ID: 30014812 [Abstract] [Full Text] [Related]
5. A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration. Yahathugoda TC, Supali T, Rao RU, Djuardi Y, Stefani D, Pical F, Fischer PU, Lloyd MM, Premaratne PH, Weerasooriya MV, Weil GJ. Parasit Vectors; 2015 Jul 15; 8():369. PubMed ID: 26168919 [Abstract] [Full Text] [Related]
6. How Thailand eliminated lymphatic filariasis as a public health problem. Rojanapanus S, Toothong T, Boondej P, Thammapalo S, Khuanyoung N, Santabutr W, Prempree P, Gopinath D, Ramaiah KD. Infect Dis Poverty; 2019 May 27; 8(1):38. PubMed ID: 31130143 [Abstract] [Full Text] [Related]
7. Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka. Rao RU, Samarasekera SD, Nagodavithana KC, Punchihewa MW, Dassanayaka TD, P K D G, Ford E, Ranasinghe US, Henderson RH, Weil GJ. PLoS Negl Trop Dis; 2016 May 27; 10(5):e0004722. PubMed ID: 27196431 [Abstract] [Full Text] [Related]
9. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration. Jones C, Ngasala B, Derua YA, Tarimo D, Reimer L, Bockarie M, Malecela MN. Parasit Vectors; 2018 Nov 13; 11(1):588. PubMed ID: 30424781 [Abstract] [Full Text] [Related]
10. Progress on elimination of lymphatic filariasis in Sierra Leone. Koroma JB, Sesay S, Conteh A, Paye J, Bah M, Sonnie M, Hodges MH, Zhang Y. Parasit Vectors; 2018 Jun 04; 11(1):334. PubMed ID: 29866207 [Abstract] [Full Text] [Related]
17. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire. Edi C, Bjerum CM, Ouattara AF, Chhonker YS, Penali LK, Méité A, Koudou BG, Weil GJ, King CL, Murry DJ. PLoS Negl Trop Dis; 2019 May 04; 13(5):e0007325. PubMed ID: 31107869 [Abstract] [Full Text] [Related]
18. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters. Wamae CN, Njenga SM, Ngugi BM, Mbui J, Njaanake HK. Acta Trop; 2011 Sep 04; 120 Suppl 1():S33-8. PubMed ID: 20933491 [Abstract] [Full Text] [Related]
20. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria. Pam DD, de Souza DK, D'Souza S, Opoku M, Sanda S, Nazaradden I, Anagbogu IN, Okoronkwo C, Davies E, Elhassan E, Molyneux DH, Bockarie MJ, Koudou BG. PLoS Negl Trop Dis; 2017 Oct 04; 11(10):e0006004. PubMed ID: 29020042 [Abstract] [Full Text] [Related] Page: [Next] [New Search]